Cargando…
Combating Drug-Resistant Mutants of Anaplastic Lymphoma Kinase with Potent and Selective Type-I(1/2) Inhibitors by Stabilizing Unique DFG-Shifted Loop Conformation
[Image: see text] Targeted inhibition of anaplastic lymphoma kinase (ALK) dramatically improved therapeutic outcomes in the treatment of ALK-positive cancers, but unfortunately patients invariably progressed due to acquired resistance mutations in ALK. Currently available drugs are all type-I inhibi...
Autores principales: | Pan, Peichen, Yu, Huidong, Liu, Qinglan, Kong, Xiaotian, Chen, Hu, Chen, Jiean, Liu, Qi, Li, Dan, Kang, Yu, Sun, Huiyong, Zhou, Wenfang, Tian, Sheng, Cui, Sunliang, Zhu, Feng, Li, Youyong, Huang, Yong, Hou, Tingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704298/ https://www.ncbi.nlm.nih.gov/pubmed/29202023 http://dx.doi.org/10.1021/acscentsci.7b00419 |
Ejemplares similares
-
In Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: The Performance of Different Selection Strategy in Selecting Virtual Screening Candidates
por: Pan, Peichen, et al.
Publicado: (2016) -
Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery
por: Sun, Huiyong, et al.
Publicado: (2016) -
How Does the L884P Mutation Confer Resistance to Type-II Inhibitors of JAK2 Kinase: A Comprehensive Molecular Modeling Study
por: Kong, Xiaotian, et al.
Publicado: (2017) -
Exploring kinase DFG loop conformational stability with AlphaFold2-RAVE
por: Vani, Bodhi P., et al.
Publicado: (2023) -
P-loop Conformation Governed Crizotinib Resistance in G2032R-Mutated ROS1 Tyrosine Kinase: Clues from Free Energy Landscape
por: Sun, Huiyong, et al.
Publicado: (2014)